Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients

NCT06421870 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06421870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06421870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Unknown status
Start date
March 1, 2024
Completion date
July 31, 2025
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases